{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:07:14Z","timestamp":1789103234119,"version":"build-2803163510"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Acute ischemic events (AIE) constitute life-threatening complications of Takayasu arteritis (TAK). This study aimed to identify vascular, inflammatory and immune factors associated with concurrent AIE in TAK patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a 10-year retrospective 1:2 matched case-control study including TAK patients without exposure to glucocorticoids, immunosuppressants, or antithrombotic agents for at least 3 months. Clinical characteristics, disease activity, inflammatory markers, and lymphocyte subsets were compared between patients with and without AIE. Three sequential multivariable logistic regression models were constructed to identify variables independently associated with AIE. Model discrimination was evaluated using receiver operating characteristic (ROC) analysis with 1000-bootstrap internal validation, while calibration and decision curve analysis (DCA) were performed as exploratory within-sample assessments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty-seven patients with AIE and 74 matched TAK control without AIE were included. The mean age at TAK onset in the AIE group was 34.92\u00a0\u00b1\u00a010.83 years (range: 16\u201358 years). Conventional markers including ESR, CRP and homocysteine showed no independent correlation with AIE. Patients with AIE presented substantially higher frequencies of coronary, anterior cerebral, middle cerebral, and femoral artery stenosis, alongside significantly elevated ITAS-2010 scores, serum IgA and IL-6 levels, and peripheral Th cell counts (all\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.05). Severe long-term functional sequelae were also more frequent in the AIE group. Multivariate analysis confirmed that stenosis at these four arterial sites, together with elevated ITAS-2010 score, IgA, IL-6, and Th cell counts, were independently associated with AIE. The fully integrated vascular-inflammation-immunity model yielded an apparent AUC of 0.942 (95%CI 0.898-0.985) and a bootstrap optimism-corrected AUC of 0.908 (95%CI 0.843-0.959), with a corrected Brier score of 0.1191. Calibration and DCA supported satisfactory within-sample model performance but should be interpreted as exploratory because of the matched case-control design.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Specific vascular stenosis, high disease activity, elevated serum IgA and IL-6 levels, and increased peripheral Th cell counts are independently associated with AIE in TAK. These findings provide additional insight into the vascular, inflammatory, and immune characteristics accompanying ischemic complications in TAK and warrant confirmation in prospective multicenter studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1866057","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:33:42Z","timestamp":1789101222000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Vascular, inflammatory and immune factors associated with acute ischemic events in Takayasu arteritis: a 10-year retrospective matched case-control study"],"prefix":"10.3389","volume":"17","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhuan","family":"An","sequence":"additional","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiao","family":"Liu","sequence":"additional","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[{"name":"Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15314","article-title":"Update on takayasu arteritis: Year in review 2024","volume":"27","author":"Mruthyunjaya","year":"2024","journal-title":"Int J Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11926-026-01214-2","article-title":"Management of takayasu arteritis - a 2026 update","volume":"28","author":"Kermani","year":"2026","journal-title":"Curr Rheumatol Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.08.001","article-title":"Pathogenesis of takayasu's arteritis: a 2011 update","volume":"11","author":"Arnaud","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead584","article-title":"Increased mortality rate in takayasu arteritis is largely driven by cardiovascular disease: a cohort study","volume":"63","author":"Jagtap","year":"2024","journal-title":"Rheumatol (Oxford)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2025.2488096","article-title":"Dysregulated serum lipid profile and atherosclerosis in untreated female takayasu arteritis patients: a propensity score-matched analysis","volume":"54","author":"Zang","year":"2025","journal-title":"Scand J Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2174\/138161212799504731","article-title":"Inflammation-induced thrombosis: mechanisms, disease associations and management","volume":"18","author":"Aksu","year":"2012","journal-title":"Curr Pharm Des"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14951","article-title":"The role of plateletcrit in takayasu arteritis: a potential biomarker for disease activity and 6-month treatment response","volume":"26","author":"Sun","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2021.08.002","article-title":"The study of novel inflammatory markers in takayasu arteritis and its correlation with disease activity","volume":"73","author":"Pathadan","year":"2021","journal-title":"Indian Heart J"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.912495","article-title":"The c-reactive protein\/albumin ratio and complete blood count parameters as indicators of disease activity in patients with takayasu arteritis","volume":"25","author":"Seringec Akkececi","year":"2019","journal-title":"Med Sci Monit"},{"key":"B10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13075-023-03016-8","article-title":"Elevated serum immunoglobulin level predicts high risk of 1-year recurrence in patients with takayasu arteritis","volume":"25","author":"Guo","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.12890\/2022_003664","article-title":"Might iga be a biomarker of disease activity in takayasu arteritis","volume":"9","author":"Vantaggio","year":"2022","journal-title":"Eur J Case Rep Intern Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/RHU.0000000000002053","article-title":"Interleukin 6 levels and disease activity in takayasu arteritis: a systematic review with meta-analysis","volume":"30","author":"Souza Pedreira","year":"2024","journal-title":"J Clin Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/art.39037","article-title":"Th1 and th17 cytokines drive inflammation in takayasu arteritis","volume":"67","author":"Saadoun","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.3390\/diagnostics12102565","article-title":"Outcome measures and biomarkers for disease assessment in takayasu arteritis","volume":"12","author":"Misra","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220149","article-title":"Measurement properties of outcome instruments for large-vessel vasculitis: a systematic literature review","volume":"50","author":"Boleto","year":"2023","journal-title":"J Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140817","article-title":"Assessment of patients with takayasu arteritis in routine practice with Indian takayasu clinical activity score","volume":"42","author":"Alibaz-Oner","year":"2015","journal-title":"J Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket128","article-title":"Development and initial validation of the Indian takayasu clinical activity score (ITAS2010)","volume":"52","author":"Misra","year":"2013","journal-title":"Rheumatol (Oxford)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.3390\/jcm14092939","article-title":"Positron emission tomography in takayasu arteritis: a review including patterns of vascular involvement across modalities and regions","volume":"14","author":"Katakura","year":"2025","journal-title":"J Clin Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.55563\/clinexprheumatol\/4bmcp0","article-title":"Comprehensive magnetic resonance imaging evaluation in a cohort of 145 patients with takayasu's arteritis. Proposal for a standardised and systematic reporting format","volume":"44","author":"Soto","year":"2026","journal-title":"Clin Exp Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330811","article-title":"The american college of rheumatology 1990 criteria for the classification of takayasu arteritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheum"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223482","article-title":"2022 american college of rheumatology\/EULAR classification criteria for takayasu arteritis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400222","article-title":"Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides","volume":"40","author":"Exley","year":"1997","journal-title":"Arthritis Rheum"},{"key":"B23","article-title":"Takayasu's arteritis in Turkey - clinical and angiographic features of 248 patients","volume":"27","author":"Bicakcigil","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2020-000809","article-title":"Incidence, prevalence and risk of stroke in patients with takayasu arteritis: a nationwide population-based study in South Korea","volume":"7","author":"Ahn","year":"2022","journal-title":"Stroke Vasc Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab308","article-title":"Risk factors for cerebral infarction in takayasu arteritis: a single-centre case-control study","volume":"61","author":"Kong","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.034445","article-title":"Cerebrovascular ischemic events in patients with takayasu arteritis","volume":"53","author":"Mirouse","year":"2022","journal-title":"Stroke"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.11.001","article-title":"Ischemic complications in takayasu's arteritis: a meta-analysis","volume":"47","author":"Kim","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"B28","doi-asserted-by":"publisher","first-page":"8607","DOI":"10.3390\/jcm14238607","article-title":"Involvement of iliofemoral arteries in PET\/CT is associated with atherosclerotic risk factors in takayasu's arteritis","volume":"14","author":"Kaymaz-Tahra","year":"2025","journal-title":"J Clin Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.3390\/cells12121640","article-title":"Vascular inflammatory diseases and endothelial phenotypes","volume":"12","author":"Immanuel","year":"2023","journal-title":"Cells"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.3390\/jcm15062308","article-title":"Inflammation and thrombophilia markers in supra-aortic takayasu arteritis-associated stroke: a digital subtraction angiography-based case control study","volume":"15","author":"Marzioglu Ozdemir","year":"2026","journal-title":"J Clin Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2025.105951","article-title":"An update on stroke and transient ischemic attack in takayasu arteritis: a systematic review and meta-analysis","volume":"93","author":"Jin","year":"2026","journal-title":"Joint Bone Spine"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.912929","article-title":"An emerging role for neutrophil extracellular traps in iga vasculitis: a mini-review","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.921864","article-title":"Iga vasculitis update: epidemiology, pathogenesis, and biomarkers","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/cells14110766","article-title":"IL-6 as a mediator of platelet hyper-responsiveness","volume":"14","author":"Webb","year":"2025","journal-title":"Cells"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1174249","article-title":"Arterial wall fibrosis in takayasu arteritis and its potential for therapeutic modulation","volume":"14","author":"Misra","year":"2023","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42667","article-title":"Pathophysiology, diagnosis, and management of takayasu arteritis: a review of current advances","volume":"15","author":"Bhandari","year":"2023","journal-title":"Cureus"},{"key":"B37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13075-025-03523-w","article-title":"Single-cell transcriptome analysis reveals cellular heterogeneity in the aortas of takayasu arteritis","volume":"27","author":"Gao","year":"2025","journal-title":"Arthritis Res Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1866057\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:33:49Z","timestamp":1789101229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1866057\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2026.1866057"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1866057","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"article-number":"1866057"}}